Clinical trial NCT06834360 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-12-13 → 2027-10-11 3. primary completion date: 2027-01-08 → 2026-11-06 4. enrollment: 210 → 216 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05521126: completion date: 2026-06-01 → 2026-08-01.
Clinical trial NCT07580599 updates: 1. start date: 2024-12-03 → 2024-12-10 2. completion date: 2026-01-01 → 2025-05-01 3. primary completion date: 2025-11-10 → 2025-05-01
Clinical trial NCT05417594 updates: 1. completion date: 2027-08-11 → 2027-10-13 2. primary completion date: 2027-08-11 → 2027-10-13
Clinical trial NCT04790344 updates: 1. completion date: 2026-06-01 → 2026-11-01 2. primary completion date: 2026-05-01 → 2026-07-01
Clinical trial NCT02651662 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-04-29 3. primary completion date: 2026-05-31 → 2026-04-29
Clinical trial NCT01692886: start date: 2012-08-01 → 2012-09-01.
Clinical trial NCT06450197: primary completion date: 2026-05-01 → 2026-04-30.
Clinical trial NCT06018337 updates: 1. completion date: 2028-07-01 → 2028-08-01 2. primary completion date: 2026-05-01 → 2026-06-01
Notification from Dominari Holdings Inc
Arch Capital Group Ltd. Announces Cash Tender Offers to Purchase up to a Capped Amount of Certain of Its Subsidiaries’ Debt Securities